Should We Cease to Perform Salvage Hysterectomy After Chemoradiation and Brachytherapy in Locally Advanced Cervical Cancer?
Authors:
Open Access
- 8 June 2019
- journal article
- research article
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 39 (6) , 2919-2926
Abstract
Background/Aim: We evaluated patients undergoing salvage hysterectomy after brachytherapy (BT) following concomitant chemoradiation (CRT) for locally advanced cervical cancers (LACC), when residual disease was suspected. Patients and Methods: From 2004 to 2013, 29 patients had a radical hysterectomy at the Gustave Roussy for suspicion of clinical and/or radiological residual disease. Outcomes, morbidities and the accuracy of the evaluation of response to CRT and BT were evaluated. Results: The rate of complications grade>IIIa was 24%, with no difference between the 14 patients with histological residual disease and the 15 with a complete response. Magnetic resonance imaging (MRI) and positron emission tomography-computed tomography (PET-CT) revealed a sensitivity of 92% and 100%, but a poor specificity of less than 40%. Three recurrences occurred in patients with residual disease (brain, rectosigmoid colon, peritoneum and lung). Conclusion: The clinical examination, MRI and PET-CT are suboptimal for diagnosing residual disease after CRT and BT. The morbidity of adjuvant hysterectomy is high and does not prevent recurrences.Keywords
This publication has 19 references indexed in Scilit:
- Post radiation hysterectomy in locally advanced cervical cancer: Outcomes and dosimetric impactRadiotherapy and Oncology, 2016
- Pre-hysterectomy cone biopsy is able to predict response in locally advanced cervical cancer patients submitted to neo-adjuvant chemoradiationEuropean Journal of Surgical Oncology, 2013
- Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancerRadiotherapy and Oncology, 2011
- Clinical evidence on PET–CT for radiation therapy planning in cervix and endometrial cancersRadiotherapy and Oncology, 2010
- Technical aspects and perspectives of the vaginal mold applicator for brachytherapy of gynecologic malignanciesBrachytherapy, 2010
- Diffusion-weighted MRI in cervical cancerEuropean Radiology, 2008
- FDG-PET imaging for the assessment of physiologic volume response during radiotherapy in cervix cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy—3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiologyRadiotherapy and Oncology, 2006
- Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group☆ (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTVRadiotherapy and Oncology, 2005
- Neoadjuvant chemotherapy for locally advanced cervix cancerCochrane Database of Systematic Reviews, 2004